Aarti Pharmalabs Ltd Dividend 2024 Record Date, Share Price, History

News: Aarti Pharmalabs Ltd, a prominent player in the pharmaceutical industry, has recently announced its dividend for the year 2024. In this article, we delve into the details of the dividend, including the record date, share price impact, and historical context.

Dividend Details

• Record Date: The record date for Aarti Pharmalabs Ltd’s dividend is February 18, 2024.
• Dividend Amount: Shareholders will receive an interim dividend of Rs. 2.00 per share (40%).
• Dividend Yield: At the current share price of Rs. 510.90, the dividend yield stands at 0.39%.

Understanding Dividends

Dividends are a way for companies to distribute profits to their shareholders. They serve as a reward for investing in the company and can be either interim (paid during the financial year) or final (paid at the end of the financial year).

Historical Context

Aarti Pharmalabs has a track record of rewarding its shareholders through dividends. In the fiscal year ending March 2023, the company declared a dividend of 40%. This consistent approach reflects the company’s commitment to creating value for its investors.

Impact on Share Price

Dividend announcements often influence share prices. While dividends provide income to shareholders, they can also affect stock prices. Investors closely monitor dividend declarations as they signal the company’s financial health and management’s confidence in future prospects.

Subscribe to Sarkari Result to stay informed. Get the latest celebrity news and detailed movie reviews in real-time. Keep up with the constantly changing world of entertainment with Sarkari Exam.

About Aarti Pharmalabs Ltd :

Aarti Pharmalabs Limited (APL) is a well-established and internationally recognized manufacturer in the pharmaceutical industry. Let’s explore more about this company:

Company Overview

• Business Focus: APL engages in the development of Active Pharmaceutical Ingredients (API), New Chemical Entities (NCE), API intermediates, Regulatory Starting Materials (RSM), Basic Starting Materials, Key Building Blocks, and Xanthine Derivatives. These are used in clinical testing and commercial production.
• Manufacturing Facilities: APL operates six state-of-the-art manufacturing plants that receive innovations from its two research and development (R&D) centers. These facilities have received accreditation from various agencies, including the USFDA, EU GMP, EDQM, KFDA, and COFEPRIS.
• Environmental Responsibility: APL strives for eco-efficiency and minimal environmental impact. It operates efficiently to enhance its eco-effectiveness.
• Health Initiatives: The company conducts regular annual health checkups for employees and provides medical and financial assistance to those affected by COVID-19, including contract workers and their families.
• Safety Commitment: APL is committed to developing and improving safety systems and fostering a safety-conscious culture.
• Sustainable Growth: Sustainability is deeply integrated into APL’s business strategy. The highly skilled team consistently delivers innovative solutions using advanced technologies and operational excellence.

Key Points:

1. Regulatory Track Record: APL boasts an impeccable regulatory track record spanning over 15 years.
2. EHS and Quality Priority: Environment, Health, and Safety (EHS) and quality are the company’s highest priorities¹.
3. Supply Capability: APL is capable of providing sustainable supply for APIs and NCEs/drug substances.
4. Cutting-Edge Technology: The company utilizes flow chemistry technology from lab scale to manufacturing scale.
5. Expertise in High Potency Molecules: APL specializes in the development and manufacturing of high-potency molecules, including anti-cancer and cytotoxic compounds.
6. Backward Integration Strength: APL’s strength lies in backward integration for raw materials.

As investors, it’s essential to keep an eye on Aarti Pharmalabs Ltd’s dividend announcements. Whether you’re a long-term investor seeking steady income or a trader looking for short-term opportunities, understanding dividend dynamics can help you make informed decisions.

Disclaimer: Please note that all content and tools on this website are provided for your convenience and are offered “as is” without warranties. The information provided, including any tool-generated output, is for informational purposes only and should not be considered investment advice or guarantees. Exercise caution, seek professional advice, and make independent judgments before acting on any information found on this site.